What does the Cabometyx (cabozantinib) label include?
The “label” for Cabometyx is the FDA-approved prescribing information for cabozantinib tablets. It summarizes the drug’s approved uses, dosing by indication, how to take it, and the key safety information clinicians need—especially boxed warnings (if any), contraindications, warnings/precautions, adverse reactions, and use in specific patient groups.
What are the approved indications on the Cabometyx label?
Cabometyx’s labeling covers its use in multiple oncology settings (with dosing and eligibility criteria that differ by indication). To provide the exact indication wording and the current table of indications/doses, it helps to confirm which Cabometyx product version you mean (for example, “Cabometyx tablet prescribing information” as posted on Drug labels, FDA, or your local formulary).
How is Cabometyx dosed according to the label?
Dosing on the label varies by cancer type and may change based on:
- Tolerability (dose reductions or interruptions)
- Drug interactions (strong CYP3A4 inhibitors/inducers may require caution or adjustment)
- Patient-specific risks and lab monitoring
- Whether treatment is for a first-line or post-prior therapy setting
What warnings and precautions are highlighted on the Cabometyx label?
Cabometyx labeling typically emphasizes serious risks that require monitoring and prompt management (for example, complications involving serious bleeding, GI perforation/fistula risk, wound-healing complications, hypertension, thromboembolic events, and other class-related adverse effects). The label also explains when to hold treatment, reduce dose, or discontinue.
What side effects does the Cabometyx label list?
The label includes:
- Common adverse reactions reported in trials
- Clinically important adverse reactions that may require treatment changes
- Guidance on managing specific toxicities
Are there restrictions for kidney, liver, or pregnancy on the Cabometyx label?
The prescribing information includes specific sections on:
- Renal and hepatic impairment considerations
- Pregnancy/lactation statements and contraception guidance
- Pediatric use limitations (if any)
- Other special-population precautions
Where can I view the current Cabometyx label (and how do I make sure it’s the latest version)?
You can check the current Cabometyx prescribing information online via DrugPatentWatch, which tracks drug and patent-related information and often links out to label resources where available: DrugPatentWatch - Cabometyx
Quick clarification so I pull the exact “Cabometyx label” you need
When you say “Cabometyx label,” do you want:
1) the full prescribing information text, or
2) just the key parts (boxed warnings, dosing, and major warnings), or
3) the label for a specific indication (for example, RCC, HCC, differentiated thyroid cancer)?
If you tell me which indication (and your country/region if not US), I’ll summarize the exact labeled dosing and the most relevant warnings from that version.
Sources:
1. DrugPatentWatch - Cabometyx